Sign In
Buy QDEL
$13.60
+0.310 (+2.33%)
At Close: Jun 03, 2026
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm
12:48am, Tuesday, 07'th Jan 2025
NEW YORK , Jan. 7, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of QuidelOrtho Corporation (NASDAQ: QDEL) breached
QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07:00am, Tuesday, 31'st Dec 2024
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical l
QuidelOrtho Announces Appointment of Two Independent Directors to its Board
07:00am, Tuesday, 10'th Dec 2024
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
01:30pm, Wednesday, 04'th Dec 2024
QDEL continues to witness growth on the back of its strong product portfolio.
Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted
03:08pm, Wednesday, 20'th Nov 2024
On Tuesday, QuidelOrtho Corporation QDEL priced the previously announced underwritten secondary offering by Carlyle Partners VI Cayman Holdings of 8.26 million shares.
Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
08:06am, Wednesday, 20'th Nov 2024
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Wednesday.
QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group
09:05pm, Tuesday, 19'th Nov 2024
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-car
QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group
04:54pm, Tuesday, 19'th Nov 2024
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-car
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm
12:39pm, Wednesday, 13'th Nov 2024
NEW YORK , Nov. 13, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of QuidelOrtho Corporation (NASDAQ: QDEL) breache
QuidelOrtho Stock Rises as Q3 Earnings & Revenues Beat Estimates
01:21pm, Friday, 08'th Nov 2024
QDEL's third-quarter results reflect growth in non-respiratory revenues along with a lowering of operating expenses year over year. However, the gross margin declines in the reported quarter.
QuidelOrtho Corporation (QDEL) Q3 2024 Earnings Call Transcript
08:54pm, Thursday, 07'th Nov 2024
QuidelOrtho Corporation (NASDAQ:QDEL ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Juliet Cunningham – Vice President, Investor Relations Brian Blaser – Presi
QuidelOrtho (QDEL) Beats Q3 Earnings and Revenue Estimates
07:41pm, Thursday, 07'th Nov 2024
QuidelOrtho (QDEL) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.90 per share a year ago.
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm
02:17pm, Thursday, 31'st Oct 2024
NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of QuidelOrtho Corporation (NASDAQ: QDEL) breach
QuidelOrtho to Participate in Three Upcoming Investor Conferences
07:00am, Monday, 28'th Oct 2024
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care
QuidelOrtho to Report Third Quarter 2024 Financial Results
07:00am, Thursday, 17'th Oct 2024
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care
